SEC Form 4 · accession 0000899243-16-019447
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Anastasios Gianakakos
Officer — President and CEO · Director
Period of report
Apr 29, 2016
Accepted (ET)
May 6, 2016 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 29, 2016 | P | 2,279 | $8.50 | A | 484,444 | D | |
| Common StockF2 | holding | — | — | — | 204,081 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan.
- F2These shares are held by the Tassos Gianakakos 2015 Annuity Trust, dated September 25, 2015. The Reporting Person as trustee has sole dispositive power over these shares.